USD $53.60
Nexlizet is a prescription medication designed to help manage cholesterol levels in individuals diagnosed with hypercholesterolemia. It combines two active ingredients, bempedoic acid and ezetimibe, to effectively lower low-density lipoprotein cholesterol (LDL-C). This medication is typically prescribed when diet and other cholesterol-lowering treatments are insufficient.
Nexlizet functions by utilizing a dual mechanism of action. Bempedoic acid works by inhibiting an enzyme in the liver responsible for cholesterol production, while ezetimibe reduces cholesterol absorption in the intestines. Together, these actions help significantly lower LDL-C levels in the bloodstream.
Nexlizet is intended for adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia, who require additional LDL-C lowering. It is particularly beneficial for those who have not achieved target cholesterol levels through diet and statin therapy alone.
Common side effects of Nexlizet may include muscle spasms, back pain, and elevated liver enzymes. It is important to discuss any potential side effects with a healthcare provider before starting treatment.
Nexlizet should be taken orally once daily, with or without food, as directed by a healthcare professional. Consistent daily use is recommended for optimal results.
Yes, Nexlizet can be used in conjunction with other cholesterol-lowering medications, such as statins. However, it is crucial to inform your healthcare provider about all medications you are currently taking to avoid potential interactions.
Nexlizet is not recommended for individuals with known hypersensitivity to any of its components or those with severe liver impairment. A healthcare provider should evaluate its suitability for each patient.
For more detailed information about Nexlizet, including clinical studies and patient support resources, please consult your healthcare provider or visit the official website.
Health Guides